Rhea
Rhea Fertility is a Singapore-headquartered reproductive health platform operating an integrated ecosystem of GenPrime IVF clinics, Rhea Labs AI software (Embryonics), and fertility wellness/mental health services across Asia, the United States, Latin America, and other markets, serving intended parents globally through owned clinics, partner networks, and medical tourism.
- Company typePrivate
- Founded-
- HeadquartersSingapore, Singapore
- Headcount251–500
- GTM typeB2B and B2C
- OfferingServices
What Rhea does
Rhea Fertility is a Singapore-headquartered, privately held reproductive health services platform that operates an integrated ecosystem spanning clinical IVF services, AI-enabled fertility technology, and wellness/mental health support. Its clinical footprint is delivered through the GenPrime sub-brand — a combination of owned fertility clinics (Singapore, Los Angeles) and partner clinics across Thailand (Genea Thailand, Legend Fertility Center), the Philippines (Manila), Malaysia (Ever Link), and Mexico (Fertilidad Integral) — supplemented by medical tourism facilitators such as Tai Orient Healthcare for Chinese patients and a joint venture with Baylor College of Medicine for an International Fertility Exchange protocol.
The technology layer sits inside Rhea Labs, built on the 2024 acquisition of Israeli AI company Embryonics. Rhea Labs develops Embryonics, a computer-vision and predictive-analytics platform using geometric AI and medical generative AI for embryo image analysis and implantation prediction, led by Head of AI/ML David Silver and Chief Architect Gilad Rave. The wellness layer combines traditional fertility wellness services with Tilly, a mental health support platform acquired in 2024. Together these pillars position Rhea as a vertically integrated platform rather than a single-clinic operator.
Rhea makes money primarily through clinical fertility services delivered across its owned and partner GenPrime network, with additional revenue mechanics from premium women's healthcare products, technology licensing of the Embryonics AI to clinic partners, medical tourism facilitation, and egg-bank/exchange services through the Baylor JV. Pricing is quote-based and not publicly disclosed. The company is venture-backed (Series A led by Thiel Capital in May 2024, with participation from Recharge Capital, Shamrock Holdings, FJ Labs, and Blue Lion Global), incubated by Recharge Capital's $200M women's health investment vehicle, and operates globally across Asia, the US, Latin America, Europe, and the Middle East.
Rhea firmographics
Firmographics- Name
- Rhea
- Legal name
- Rhea Fertility
- Website
- https://rhea-fertility.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Rhea Fertility is a Singapore-headquartered reproductive health platform operating an integrated ecosystem of GenPrime IVF clinics, Rhea Labs AI software (Embryonics), and fertility wellness/mental health services across Asia, the United States, Latin America, and other markets, serving intended parents globally through owned clinics, partner networks, and medical tourism.
- Ownership category
- akta.pro rank
Rhea industry classification
Industry- Product category
- Reproductive Health Services
- NAICS
- Family Planning Centers (62141), Family Planning Centers (621410)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC)
- akta.pro secondary industries
- Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD), Fertility/IVF & Reproductive Tourism Agencies (THAKAIAF)
Keywords
Where Rhea is headquartered
LocationHeadquarters
- HQ city
- Singapore
- HQ country
- Singapore
- HQ region
- Asia
Offices10 records
Markets served
Rhea business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain
Revenue model
- Clinical Fertility Services: Revenue from owned and operated GenPrime fertility clinics providing IVF, fertility treatments, and related medical services across Asia, United States, and Latin America.
- Partner Clinic Network: Revenue from partner IVF clinics and strategic holdings in fertility clinics across multiple regions including Mexico, Thailand, and Southeast Asia.
- Fertility Wellness Products: Premium women's healthcare products and wellness services.
- IVF AI Technology Licensing: Rhea Labs provides AI technology including Embryonics software for embryo analysis and implantation prediction to clinic partners.
- Medical Tourism Services: Facilitation services for international fertility patients through partners like Tai Orient Healthcare.
- Egg Bank and Exchange Protocol: Egg banking services and international fertility exchange protocols including the Baylor College of Medicine JV.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels3 records
Rhea product offering
Product offeringCore offering
Rhea Fertility operates an integrated ecosystem of fertility clinical services, AI technology, and wellness support for intended parents globally. Its GenPrime network delivers IVF and fertility treatments through owned and partner clinics across Asia, the United States, Latin America, Europe, and the Middle East, while its Rhea Labs division licenses Embryonics AI software for embryo analysis and implantation prediction to clinic partners.
Product overview
Rhea Fertility operates as an integrated ecosystem platform combining clinical services, technology, and wellness offerings. The core platform comprises three main pillars: Clinical Services (IVF and fertility treatments through clinic network), Rhea Labs (AI/technology division with Embryonics software), and Fertility Wellness (mental health and support services). The GenPrime sub-brand represents Rhea's owned and partner fertility clinic network across Asia, US, and Latin America. Rhea Labs houses the acquired Embryonics IVF AI software for embryo analysis and implantation prediction. The ecosystem serves target regions including Asia, Europe/Middle East, United States, and Latin/South America through connected networks of state-of-the-art clinics and technology partnerships.
Differentiator
Problem solved
Functional benefit
Brands
- GenPrime: Fertility clinic network brand offering IVF and fertility wellness services across Asia, US, and Latin America
- Rhea Labs
- Embryonics
Products and services
- GenPrime Fertility Clinics Owned and partner-operated fertility clinic network offering IVF, fertility treatments, and fertility wellness services to intended parents across Singapore, Thailand, the Philippines, Malaysia, the United States, and Latin America.
- Embryonics IVF AI Software AI-powered IVF software using geometric AI, medical generative AI, advanced image processing, and depth camera technology to analyze embryo images and predict implantation success; licensed to clinic partners globally.
- Tilly Mental Health Support Mental health and psychological support platform integrated into Rhea's Fertility Wellness pillar to provide emotional support throughout the fertility journey for intended parents.
- International Fertility Exchange Cross-border fertility exchange protocol and egg banking service operated through a joint venture with Baylor College of Medicine, facilitating international fertility patients and egg bank/exchange services.
- Fertility Wellness Services
Companies that use Rhea
Customer profileNamed customers4 records
Segments2 records
Ideal customer profiles3 records
Rhea technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature3 records
Rhea partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core, strategic and partner.
- EmbryonicscoreAcquired by Rhea to form Rhea Labs. Provides AI-powered IVF software for embryo analysis and implantation prediction. Team led by David Silver and Gilad Rave joined Rhea.
- TillycoreAcquired by Rhea Fertility to enhance mental health support in fertility care services.
- Genea BiomedxstrategicSigned MOU to lead innovation in assisted reproductive technology. Partnership focused on advancing ART capabilities.
- Genea FertilitystrategicStrategic partnership to provide leading fertility care in Thailand and Southeast Asia through GenPrime Genea Thailand clinic.
- Baylor College of MedicinestrategicJoint venture for International Fertility Exchange protocol serving international fertility patients.
- STO+G (Dr. Steven Teo, Dr. Jessie Phoon)partnerPartner IVF doctors in Singapore serving patients through Rhea's connected network.
- Tai Orient HealthcarepartnerMedical tourism facilitator for GenPrime, helping patients from China access fertility services.
- Fertilidad IntegralpartnerStrategic holding and partner IVF clinic in Mexico City serving Latin American markets.
Scale indicators4 records
Recent moves7 records
Expansion highlights6 records
Rhea competitors and assessment
Company assessmentDirect peers
- Kindbody: US-headquartered fertility clinic network offering IVF, egg freezing, and women's health services with employer partnerships. Directly comparable as a tech-enabled fertility clinic operator pursuing a similar integrated model.
- Genea Fertility: Australia-headquartered global IVF clinic operator with which Rhea has a strategic partnership for GenPrime Genea Thailand. Directly comparable as a multi-region fertility clinic network with technology-forward positioning.
- Prelude Network (Inception Fertility): US-based fertility clinic network and parent to Reproductive Medicine Associates. Comparable as a multi-clinic fertility services platform pursuing integrated technology and care models.
Broad incumbents
- CooperSurgical: US-based medical device and fertility supplies company providing IVF lab equipment, consumables, and fertility services. Comparable as a B2B supplier of fertility technology and adjacent clinical services globally.
- Virtus Health: Australia-listed, multi-region IVF and fertility services operator with clinics across Australia, Ireland, UK, Singapore, and Denmark. Comparable as a scaled incumbent in the same clinical fertility services space with overlapping Asia-Pacific footprint.
- Monash IVF Group: Australia-listed fertility services provider operating IVF clinics and embryology labs across Australia and Southeast Asia. Comparable as a regional incumbent fertility clinic operator with Asia-Pacific presence.
- Progyny: US-listed fertility benefits management company partnering with employer-sponsored plans. Comparable in addressing the fragmented employer/patient fertility journey, though operates as a benefits layer rather than clinic operator.
Emerging players
- Maven Clinic: US-based digital health platform for women's and family health including fertility. Comparable as a technology-enabled women's reproductive health platform, though focuses on virtual care rather than clinic operations.
- Carrot Fertility: US-based fertility benefits and care navigation platform serving employers. Comparable as a tech-enabled fertility services intermediary, though focused on benefits/payer rather than clinic operations.
- TMRW Life Sciences: US-based fertility technology company offering automated cryostorage for eggs and embryos. Comparable as a venture-backed technology company targeting IVF clinic infrastructure with adjacent technology positioning.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Rhea social profiles
Digital presenceRhea financial estimates
Financial estimateRevenue estimate
Valuation estimate
Rhea leadership team
Management profileNumber of profiles
Profiles10 records
Rhea subsidiaries and ownership
Company hierarchySubsidiaries4 records
Rhea funding detail
Funding detailFunding overview
Funding rounds1 record
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Rhea M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Rhea
What does Rhea do?
Rhea Fertility operates an integrated ecosystem of fertility clinical services, AI technology, and wellness support for intended parents globally. Its GenPrime network delivers IVF and fertility treatments through owned and partner clinics across Asia, the United States, Latin America, Europe, and the Middle East, while its Rhea Labs division licenses Embryonics AI software for embryo analysis and implantation prediction to clinic partners.
Is Rhea a public or private company?
Rhea is a private company. It is classified as venture growth investor backed and is currently operating.
When was Rhea founded?
Rhea was founded in -1. It employs 251 to 500 people.
Where is Rhea based?
Rhea is headquartered in Singapore, Singapore, in the Asia region.
How does Rhea make money?
Six revenue lines are on record. Clinical Fertility Services are the primary driver. The others are partner Clinic Network, fertility Wellness Products, IVF AI Technology Licensing, medical Tourism Services and egg Bank and Exchange Protocol.
Who are Rhea's main competitors?
Direct peers on record are Kindbody, Genea Fertility and Prelude Network (Inception Fertility). Broad incumbents are CooperSurgical, Virtus Health, Monash IVF Group and Progyny. Emerging players are Maven Clinic, Carrot Fertility and TMRW Life Sciences.
Does Rhea have an API?
No public API is recorded for Rhea.
What industry is Rhea in?
Rhea's product category is Reproductive Health Services. Its primary akta.pro industry code is HLAKAJAC, Reproductive Endocrinology & Infertility (IVF/Fertility), with a secondary code of HLAFAJAD, Fertility, Reproductive Endocrinology & IVF Centers. Its NAICS code is 62141 and its SIC code is 8093.